Prevalence and Molecular Identification of Human Schistosomiasis (NCT07482215) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Prevalence and Molecular Identification of Human Schistosomiasis
359 participantsStarted 2026-05
Plain-language summary
Schistosomiasis remains one of the most important parasitic diseases of public health concern, particularly in developing countries including Egypt. It is caused by a trematode worm (blood flukes) of the genus Schistosoma
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged ≥ 5 years of both sexes attending Assiut Governorate hospitals during the study period.
* Patients clinically suspected of having schistosomiasis (urinary and/or intestinal) or referred for parasitological examination.
* Individuals (or guardians, in case of minors) who provide written informed consent.
* Patients willing to provide the required biological samples (urine and/or stool).
Exclusion Criteria:
* Patients Received praziquantel within the last 3 months before sample collection
* Patients with incomplete clinical or epidemiological data.
* Patients refusing participation or sample collection.
* Improperly collected, contaminated, or insufficient samples.
* Patients suffering from severe comorbid conditions that may interfere with the interpretation of results (e.g., advanced hepatic or renal failure).
* children with congenital urinary or intestinal anomalies.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
prevalence of human schistosomiasis in the study participants